AIDS Vaccine Development

The International AIDS Vaccine Initiative (IAVI) is a global non-profit scientific organization dedicated to developing vaccines and antibodies for HIV and other neglected infectious diseases. IAVI operates its own research laboratories and collaborates with a vast network of academic, pharmaceutical, and government partners to accelerate the development of affordable, accessible health technologies. Their portfolio includes advanced work on germline-targeting HIV vaccines and viral vector platforms for emerging pathogens like Lassa fever and Ebola. By bridging the gap between basic research and clinical implementation, IAVI plays a critical role in the global health landscape, particularly for low-income countries.